| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Division of Endocrinology (L.G., E.U.F., K.L.H., B.B.K.) Department of Medicine at Harvard Medical School and Beth Israel Hospital and The Dana Farber Cancer Institute (P.E.) Boston, Massachusetts 02215
Recent studies suggest that the ras-map kinase and PI3-kinase cascades converge. We sought to determine whether PI3-kinase is downstream of ras in insulin signaling in a classic insulin target cell. We generated a recombinant adenovirus encoding dominant negative ras by cloning the human H-ras cDNA with a ser to asn substitution at amino acid 17 (rasasn17) into the pACCMVpLpA vector and cotransfecting 293 cells with the pJM17 plasmid containing the adenoviral genome. Efficiency of gene transfer was assessed by infecting fully differentiated 3T3L1 adipocytes with a recombinant adenovirus expressing ß-galactosidase (ß-gal); greater than 70% of cells were infected. Infection of adipocytes with rasasn17 resulted in 10-fold greater expression than endogenous ras. This high efficiency gene transfer allowed biochemical assays. Insulin stimulation of ras-GTP formation was inhibited in rasasn17-expressing cells. Map kinase gel mobility shift revealed that insulin (1 uM) or epidermal growth factor (100 ng/ml) resulted in the appearance of a hyperphosphorylated species of p42 map kinase in uninfected cells and those expressing ß-gal but not in cells expressing rasasn17. In contrast, insulin increased IRS-1-associated PI3-kinase activity approximately 10-fold in control cells and high level overexpression of rasasn17 did not impair this effect. Similarly, insulin and epidermal growth factor activation of total (no immunoprecipitation) PI3-kinase activity in both cytosol and total cellular membranes and insulin stimulation of glucose transport were not affected by expression of dominant negative ras. Thus, adenovirus-mediated gene transfer is effective for studying insulin signaling in fully differentiated insulin target cells. Inhibition of ras activation abolishes insulin-stimulated phosphorylation of map kinase but does not affect insulin stimulation of PI3-kinase activity. In normal cell physiology, PI3-kinase does not appear to be downstream of ras in mediating the actions of insulin.
This article has been cited by other articles:
![]() |
X. Hou, E. W. Arvisais, C. Jiang, D.-b. Chen, S. K. Roy, J. L. Pate, T. R. Hansen, B. R. Rueda, and J. S. Davis Prostaglandin F2{alpha} Stimulates the Expression and Secretion of Transforming Growth Factor B1 Via Induction of the Early Growth Response 1 Gene (EGR1) in the Bovine Corpus Luteum Mol. Endocrinol., February 1, 2008; 22(2): 403 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, S. Epperson, L. Makhsudova, B. Ito, J. Suarez, W. Dillmann, and F. Villarreal Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2478 - H2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Harmon, D. S. Paul, and Y. M. Patel MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E758 - E766. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance Am J Physiol Cell Physiol, August 1, 2004; 287(2): C548 - C557. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gnudi, G. Viberti, L. Raij, V. Rodriguez, D. Burt, P. Cortes, B. Hartley, S. Thomas, S. Maestrini, and G. Gruden GLUT-1 Overexpression: Link Between Hemodynamic and Metabolic Factors in Glomerular Injury? Hypertension, July 1, 2003; 42(1): 19 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Briaud, M. K. Lingohr, L. M. Dickson, C. E. Wrede, and C. J. Rhodes Differential Activation Mechanisms of Erk-1/2 and p70S6K by Glucose in Pancreatic {beta}-Cells Diabetes, April 1, 2003; 52(4): 974 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Robey, O. S. Ruiz, J. Baniqued, D. Mahmud, D. J. D. Espiritu, A. A. Bernardo, and J. A. L. Arruda SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO3 cotransport activity in renal epithelial cells Am J Physiol Renal Physiol, May 1, 2001; 280(5): F844 - F850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Sajan, M. L. Standaert, G. Bandyopadhyay, M. J. Quon, T. R. Burke Jr., and R. V. Farese Protein Kinase C-zeta and Phosphoinositide-dependent Protein Kinase-1 Are Required for Insulin-induced Activation of ERK in Rat Adipocytes J. Biol. Chem., October 22, 1999; 274(43): 30495 - 30500. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Law, P. Norgaard, L. Gnudi, B. B. Kahn, H. S. Poulson, and H. L. Moses Inhibition of DNA Synthesis by a Farnesyltransferase Inhibitor Involves Inhibition of the p70s6k Pathway J. Biol. Chem., February 19, 1999; 274(8): 4743 - 4748. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Kao, B. P. Ceresa, S. R. Santeler, and J. E. Pessin Expression of a Dominant Interfering Dynamin Mutant in 3T3L1 Adipocytes Inhibits GLUT4 Endocytosis without Affecting Insulin Signaling J. Biol. Chem., September 25, 1998; 273(39): 25450 - 25457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |